Table 1.
The characteristic of clinical uropathogenic E. coli strains selected for the study; 0 – lack of the gene, 1 – gene presence, S – sensitive, I – intermediately sensitive. CIP – ciprofloxacin, NOR – norfloxacin, OFX – ofloxacin, AML – amoxicillin, AMC – amoxicillin/clavulanate, PRL – piperacillin, CAZ – ceftazidime, FOX – cefoxitin, CTX – cefotaxime, IMI – imipenem, GN – gentamycin, TN – tobramycin, AK – amikacin, NET – netilmicin, NI – nitrofurantoin, W – trimethoprim, SXT – trimethoprim/sulfamethoxazole.
|
E. coli wild-type strains |
1 |
5 |
6 |
16 |
84 |
|
|---|---|---|---|---|---|---|
| Phylogenetic group |
A |
A |
B |
B |
B |
|
| Biofilm formation level (A531) | 0.09 | 0.07 | 0.1 | 0.09 | 0.06 | |
| Virulence factors’ genes | papC | 0 | 0 | 0 | 1 | 1 |
| sfaE/D | 0 | 0 | 1 | 1 | 1 | |
| cnf1 | 0 | 0 | 1 | 0 | 1 | |
| usp | 0 | 0 | 1 | 1 | 1 | |
| fimG/H | 1 | 1 | 1 | 1 | 1 | |
| hlyA | 0 | 0 | 1 | 0 | 1 | |
| Drug-resistance genes | blaTEM-1 | 0 | 0 | 0 | 0 | 0 |
| sul1 | 0 | 1 | 0 | 0 | 0 | |
| sul2 | 0 | 1 | 0 | 0 | 0 | |
| blaCTX-M1 | 0 | 0 | 0 | 0 | 0 | |
| blaSHV | 0 | 0 | 0 | 0 | 0 | |
| blaOXA-1 | 0 | 0 | 0 | 0 | 0 | |
| blaCMY | 0 | 0 | 0 | 0 | 0 | |
| aac-(3)-II | 0 | 0 | 0 | 0 | 0 | |
| Drug-resistance profiles | CIP | S | S | S | S | S |
| NOR | S | S | S | S | S | |
| OFX | S | S | S | S | S | |
| AML | S | S | S | S | S | |
| AMC | S | S | S | S | S | |
| PRL | S | S | S | S | S | |
| CAZ | S | I | S | S | S | |
| FOX | S | S | S | S | S | |
| CTX | S | S | S | S | S | |
| IMI | S | S | S | S | S | |
| GN | S | I | I | I | S | |
| TN | S | I | I | I | S | |
| AK | S | S | S | S | S | |
| NET | I | S | I | I | S | |
| NI | S | S | S | S | S | |
| W | S | S | S | S | S | |
| SXT | S | S | S | S | S | |